D.A. Davidson & Co. Heron Therapeutics, Inc. Transaction History

D.A. Davidson & Co.

$12 Billion
Q3 2024

A detailed history of D.A. Davidson & Co. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, D.A. Davidson & Co. holds 213,630 shares of HRTX stock, worth $239,265. This represents 0.0% of its overall portfolio holdings.

Number of Shares

213,630

Previous 218,530 2.24%

Holding current value

$239,265

Previous $764,000 44.37%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.73 - $3.67 $8,477 - $17,983	-4,900 Reduced 2.24%	213,630 $425,000
Q2 2024 Jul 31, 2024	BUY	$2.32 - $3.86 $110,269 - $183,465	47,530 Added 27.8%	218,530 $764,000
Q1 2024 May 13, 2024	BUY	$1.71 - $3.06 $240,939 - $431,154	140,900 Added 468.11%	171,000 $473,000
Q4 2023 Feb 09, 2024	SELL	$0.54 - $1.82 $5,670 - $19,110	-10,500 Reduced 25.86%	30,100 $51,000
Q3 2023 Nov 08, 2023	SELL	$0.97 - $1.8 $209,332 - $388,452	-215,807 Reduced 84.17%	40,600 $41,000
Q2 2023 Aug 10, 2023	BUY	$1.11 - $2.88 $38,807 - $100,690	34,962 Added 15.79%	256,407 $297,000
Q1 2023 Apr 25, 2023	BUY	$1.51 - $3.25 $71,951 - $154,862	47,650 Added 27.42%	221,445 $334,000
Q4 2022 Feb 03, 2023	SELL	$2.25 - $4.67 $51,709 - $107,325	-22,982 Reduced 11.68%	173,795 $434,000
Q3 2022 Nov 07, 2022	SELL	$2.66 - $5.37 $57,299 - $115,675	-21,541 Reduced 9.87%	196,777 $830,000
Q2 2022 Jul 28, 2022	SELL	$2.3 - $6.29 $8,795 - $24,052	-3,824 Reduced 1.72%	218,318 $609,000
Q1 2022 May 12, 2022	BUY	$4.63 - $9.94 $86,488 - $185,679	18,680 Added 9.18%	222,142 $1.27 Million
Q4 2021 Jan 31, 2022	BUY	$8.35 - $12.6 $273,546 - $412,776	32,760 Added 19.19%	203,462 $1.86 Million
Q3 2021 Nov 15, 2021	BUY	$10.13 - $15.0 $30,653 - $45,390	3,026 Added 1.8%	170,702 $1.83 Million
Q2 2021 Aug 10, 2021	BUY	$13.27 - $18.48 $595,544 - $829,363	44,879 Added 36.55%	167,676 $2.6 Million
Q1 2021 May 07, 2021	BUY	$14.49 - $20.72 $497,528 - $711,441	34,336 Added 38.81%	122,797 $1.99 Million
Q4 2020 Feb 10, 2021	BUY	$14.61 - $22.14 $117,347 - $177,828	8,032 Added 9.99%	88,461 $1.87 Million
Q3 2020 Nov 02, 2020	BUY	$13.67 - $17.77 $23,375 - $30,386	1,710 Added 2.17%	80,429 $1.19 Million
Q2 2020 Aug 10, 2020	BUY	$10.89 - $21.47 $509,129 - $1 Million	46,752 Added 146.25%	78,719 $1.16 Million
Q1 2020 May 05, 2020	BUY	$10.23 - $24.56 $327,022 - $785,109	31,967 New	31,967 $375,000

Others Institutions Holding HRTX

# of Institutions

180

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $133M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account